Unlocking Sanctuary Sites: The Efficacy of Brexucabtagene Autoleucel in Ocular B-ALL Relapse

Am J Hematol. 2025 Mar;100(3):483-487. doi: 10.1002/ajh.27572. Epub 2024 Dec 24.

Authors

Ludovica Calabretta¹, Patrizia Zappasodi², Carlo Di Biase³, Cristina Picone², Elisa Roncoroni², Marianna Rossi², Antonio Bianchessi², Irene Defrancesco², Caterina Zerbi², Beatrice Ferrari², Erica Consensi², Gianluca Martini¹, Claudia Patricia Tobar Cabrera¹, Claudia Battista¹, Alessandro Mazzacane¹, Francesco Romano¹, Giulia Losi¹, Alessia Taurino², Luca Arcaini^{1

2}, Nicola Polverelli²

Affiliations

¹ Department of Molecular Medicine, Università di Pavia, Pavia, Italy.
² Unit of Bone Marrow Transplantation and Cellular Therapies, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
³ Division of Ophthalmology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 39718764
DOI: 10.1002/ajh.27572

No abstract available

Publication types

Case Reports